1. Pink Sheet
  2. >>Geography
  3. >>Europe

People In Brief

 
• By Lisa Gillespie

Williams stars in Clear Eyes campaign; industry veteran Brown joins Innovus as CFO; Mannatech makes promotions, addition; Loew heads Sanofi’s European commercial operations; Bayer HealthCare moves Schubmehl to CIO; more People In Brief.

Actress and singer Vanessa Williams, as spokeswoman for Prestige Brands Holdings Inc.’s Clear Eyes eye drops, stars in an advertising campaign including TV commercials launching in June and in online ads on the brand’s website and Facebook page. The Tarrytown, N.Y.-based firm on May 30 said Williams is an ideal spokeswoman because of her “beautiful, crystal clear eyes and longtime advocacy for eye health.” Having Williams promote Clear Eyes marks a stylistic shift from the previous star of the brand’s advertising, political commentator and satirist Ben Stein Also see "Prestige Brands’ OTC Revenue Climbs With Boost In Advertising" - Pink Sheet, 14 November, 2011..

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

UK MHRA Tackles Staff Burnout As It Eliminates Filings Backlog

 
• By Vibha Sharma

Efforts by the medicines regulator, the MHRA, to clear all backlogs relating to its statutory functions and maintaining predictable review timeframes have put pressure on its staff.

Why Successful Companies Are ‘Tough On Themselves’ When It Comes To HTA

 
• By Eliza Slawther

Pharmaceutical companies need to “pressure test” their clinical development strategies early for health technology assessment purposes, particularly in light of the new EU HTA Regulation, a life sciences consultant says.

EU CHMP Opinions And MAA Updates

 
• By Neena Brizmohun

This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.

Vertex’s Alyftrek For CF Among Six Orphans On Track For Pan-EU Approval

 
• By Eliza Slawther

The European Medicines Agency has recommended 16 drugs for EU-wide approval, including Vertex’s cystic fibrosis drug Alyftrek and five other orphans.

More from Geography

EU CHMP Opinions And MAA Updates

 
• By Neena Brizmohun

This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.

Updated: Makary Backs New Novavax COVID-19 Trial, Political Officials Take Over Product Review

 
• By Sarah Karlin-Smith

In an unusual move, Tracy Beth Høeg, a special assistant to FDA Commissioner Martin Makary, is leading the continued negotiations on Novavax’s delayed COVID-19 vaccine approval.

340B Not Designed To Pass Savings Directly To Patients, Hospitals Tell Senate Committee

 
• By Cathy Kelly

Respondents to a Senate investigation that could re-energize 340B reform efforts said hospitals offer patient assistance programs and use 340B revenue for “capital improvement projects” and “community benefit programs,” though they do not account for specific program revenue allocations.